Discover Great Companies Discover Great Clients
Popularity  15.3万   |   Followers  146   |   Likes  73   |   Feedback  136 Claim this company
No.120 Changsha City Popularity Ranking No.34 Yuelu District No.178 Hunan Prov No.1 Pharmaceuticals Industrial No.3 Sheng Ming Ke Xue No.3 Xin Yao R&D No.3 Biotechnology Pharmaceuticals No.3 Biological Products No.5 Biopharmaceuticals No.5 Yi Yao Jing Ji No.5 Zhong Pharmaceuticals No.5 Sheng Wu Ke Ji / Biotechnology Engineering No.5 Lin Chuang Yi Xue No.6 Health Services No.6 Jian Kang Chan Industries 驰名商标 省长质量奖 高新技术企业 企业技术中心 守合同重信用企业 AAA级信用企业 NMPA认证
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 29年
  • Industry: Pharmaceutical/Bioengineering 、 Raw Material Processing 、 Medical Devices/Equipment
  • Full name: Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd.。

Development Stage

  • Stage: IPO上市, 主板, 上交所。
  • Ranking: Ranked #120 in Changsha City by popularity Ranked #1 in Changsha Pharmaceuticals Industrial Company by popularity Ranked #3 in Changsha Sheng Ming Ke Xue Company by popularity Ranked #3 in Changsha Xin Yao R&D Company by popularity Ranked #3 in Changsha Biotechnology Pharmaceuticals Company by popularity
  • Honors: 2023中国高新技术企业慈善公益500强 2023中国中成药企业100强 驰名商标 省长质量奖 According to algorithm
  • News: 2025-11-11:方盛制药:吲哚布芬片获得药品注册证书。
  • Salary: 56.2% of positions earn 10-30K, In 2026 vs last yeargrew by 19%.。Master's salary: ¥29.9K, Doctorate salary: ¥22.5K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 32.3%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 20%, "Other (R&D and Technical)": 9.4%。
  • Recruiting: In 2026 vs 2025decreased by 1%. Demand for highly educated talent: Master's: 36, Doctorate: 3.
  • Requirement: Education: 本科 leads with 63.4%. Experience: 5-10年 leads with 35.4%.
  • Region: Distributed across 10 regions, 长沙: 78.3%, 广州: 7%, 珠海: 5.2%, 永州: 1.4%.

About the Company

Fangsheng Pharmaceutical was founded in June 2002. It is a high-quality, comprehensive, and research-oriented pharmaceutical and health industry group integrating pharmaceutical industry, medical services, and big health business. It has several subsidiaries. On December 5, 2014, it was successfully listed on the Shanghai Stock Exchange and formally entered the capital market (stock code: 603998). From the factory construction to now, Fangsheng has risen rapidly with steady development speed, growing into a benchmark enterprise in the pharmaceutical industry in Hunan Province. It has been successively awarded the National Torch Plan Key High-tech Enterprise, China National Medicine Top 100 Brand Enterprise, China Pharmaceutical Industry AAA Integrity Enterprise, China Outstanding Private Enterprise, National Contract-honoring and Promise-keeping Enterprise, Hunan Provincial Governor Quality Award Enterprise, and the first batch of demonstration pharmaceutical enterprises in Hunan Province.
Fangsheng takes "Your health, Fangsheng's pursuit" as its corporate mission, and takes "new drug R&D capability" as its core competitive advantage. It integrates global new drug R&D resource advantages, builds a high-level R&D team, constructs a "1+N model" new drug R&D system, and implements an integrated management and decentralized operation R&D strategy with the R&D center of Fangsheng Group headquarters as the main body and subsidiaries as support. The international, forward-looking, and holistic R&D strategic layout enables Fangsheng to achieve common development and prosperity in the three fields of traditional Chinese medicine, chemical drugs, and biological drugs. In the field of traditional Chinese medicine, Fangsheng has successfully developed several brand series products such as "Xinxue'an" brand for cardiovascular and cerebrovascular departments, "Jinbeibei" brand for pediatrics, "Meiershu" brand for gynecology, and "Fangshengtang" brand for orthopedics. In the chemical drug field, Fangsheng is committed to focusing on the development of blockbuster drugs with independent intellectual property rights and prevention and treatment of major diseases, forming core technology and innovation strength. In the biological drug field, Fangsheng holds a controlling stake in the National Engineering Research Center for Gene Drug Engineering approved by the National Development and Reform Commission in the field of genetic engineering drugs - Guangdong Jida Gene Drug Engineering Research Center, accelerating the layout speed in the biological drug field. Fangsheng currently has a nationally recognized enterprise technology center, a national postdoctoral research workstation, and the Hunan Provincial Cardiovascular and Cerebrovascular Drug Engineering Technology Research Center. It undertakes 2 major national new drug development science and technology major projects and several provincial and ministerial science and technology projects. It has obtained more than 100 drug production approvals, nearly 20 new drug certificates, and more than 20 invention patents. The rich product reserve provides strong support for realizing Fangsheng's strategy, and in the future it will provide a new commanding height for the development of Hunan and even China's pharmaceutical economy.
Fangsheng has established a nationwide marketing network and is gradually building a market sales network covering hospitals at all levels and chain and single pharmacies in various provinces, cities, and counties. While based on the domestic market, Fangsheng actively explores the international market and takes the road of internationalization. In 2016, it invested in Lipo, an American biotechnology company specializing in the R&D of anti-tumor drugs, entering the global anti-cancer drug market worth hundreds of billions of dollars, laying a solid foundation for the internationalization of pharmaceutical preparations and the entry of the Fangsheng brand into the international market.
Fangsheng has multiple production bases in Changsha, Hainan, and other places. It organizes production strictly in accordance with the new GMP and excellent performance system requirements, establishes a complete quality control and assurance system, implements whole-process and full-staff quality management, and ensures the quality and safety of people's medication. The Fangsheng Pharmaceutical Industrial Park located in Changsha High-tech Zone covers an area of 150 mu with a total construction area of 230,000 square meters. After full completion, the production capacity required for the company's strategic development will receive strong support. In the future, Fangsheng will also purchase land to build factories according to the needs of enterprise development, continuously expand production capacity, and lay a solid foundation for realizing the "century-old Fangsheng".
In recent years, on the basis of continuously developing the core business of pharmaceutical industry, Fangsheng has gradually expanded strategic sectors such as medical services and big health business. The businesses of its subsidiaries are booming, effectively achieving industrial chain integration and strategic synergy. In the future, Fangsheng will leverage the power of capital to drive industrial development, ultimately realize the "one body with two wings" strategic layout of pharmaceutical industry, medical services, and big health business, create a high-quality, comprehensive, and research-oriented big health industry aircraft carrier, realize the Fangsheng dream, and achieve the health dream!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Fangsheng Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Fangsheng Pharmaceutical How Fast Is Hiring Growing? (295 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 91%
  • 2024: Up 32%
  • 2023: Up 165%
  • 2022: Down 67%
Fangsheng Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Fangsheng Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Interns 1 Master's 36 Doctorate 3
No.15
Company Recruitment Ranking in Changsha City 򀀩
No.1392
Recruitment Growth Ranking in Changsha City 򀀩
N/A
Intern Talent Ranking in Changsha City 򀀩
Note: How fast is hiring at Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd. growing? Fangsheng Pharmaceutical2026: 648 openings (down 1%), 2025: 652 openings (up 91%), 2024: 342 openings (up 32%), 2023: 260 openings (up 165%), 2022: 98 openings (down 67%), 2021: 297 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Fangsheng Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 133%
  • 2024: Down 9%
  • 2023: Up 283%
  • 2022: Up 50%
Fangsheng Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd. growing? Fangsheng PharmaceuticalMaster's recruitment over the years: 2025: 49 openings (up 133%), 2024: 21 openings (down 9%), 2023: 23 openings (up 283%), 2022: 6 openings (up 50%), 2021: 4 openings. Fangsheng Pharmaceutical master talent ranking in Changsha: #18, Fangsheng Pharmaceutical master salary mostly around 20-50K.

Fangsheng Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
+200%
Growth Rate
2026 vs 2025
Fangsheng Pharmaceutical Doctoral Hiring by Year: 2026 — 4 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.39
Doctoral Demand Ranking in Changsha City 򀀩
¥15-30K
Doctoral Salary 򀀩
How fast is doctoral hiring at Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd. growing? Fangsheng PharmaceuticalDoctorate recruitment over the years: 2026: 6 openings (up 59%), 2025: 2 openings (up 133%). Fangsheng Pharmaceutical doctorate talent ranking in Changsha: #39, Fangsheng Pharmaceutical doctorate salary mostly around 15-30K.

Fangsheng Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd.? Based on an analysis of Fangsheng Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 32.3%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 20%, "Other (R&D and Technical)": 9.4%, "Scientific Research": 4.5%, "Computer/Network/Technology": 3.7%, "Mechanical/Instrumentation": 1.5%. For reference only.

Fangsheng Pharmaceutical — What Are the Salaries Like? (839 records)

Manage
Fangsheng Pharmaceutical Salary Overview
salary range: 6K - 50K, 56.2% of roles pay ¥10-30K
Note: salary statistics are based on 839 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd.?Fangsheng Pharmaceutical56.2% of positions earn 10-30K, Undergraduate salary: ¥。Changsha salary ranking top 5,经营管理类 average salary ¥26.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Fangsheng Pharmaceutical

(More)
Are salaries high at Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd.? We provide: Analyst, 临床, Researcher, QA, Quality, Vice President, Leasing Manager, QC, Medical Director, Team Leader, General Manager, Registration Supervisor, Regional Manager, Business Manager, Production Manager, Operations, Workshop, HR, Drug Registration Specialist, Project Manager. Click to view detailed salary analysis by job.

Fangsheng Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国高新技术企业慈善公益500强:

  • NO.250 2023中国高新技术企业慈善公益500强 >
  • NO.165 2022中国高新技术企业慈善公益500强 >

Yes, ranked in 中国中成药企业100强:

  • NO.68 2023中国中成药企业100强 >
  • NO.58 2022中国中成药企业100强 >
  • NO.66 2021中国中成药企业100强 >

Job Category

  • 经营管理类
    40.9% of total 40.9%
  • 医疗卫生/美容保健类
    32.3% of total 32.3%
  • 生物/制药/化工/环保类
    20.1% of total 20.1%
  • 质量管理类
    17.9% of total 17.9%

Education

  • 本科
    63.4% of total 63.4%
  • 大专
    16.4% of total 16.4%
  • 硕士
    11.4% of total 11.4%
  • 不限
    4.5% of total 4.5%

Experience

  • 5-10年
    35.4% of total 35.4%
  • 3-5年
    25.6% of total 25.6%
  • 不限
    25.3% of total 25.3%
  • 1-3年
    13.7% of total 13.7%
View Detailed Analysis

What does Hunan Fangsheng Pharmaceutical Joint-Stock Co., Ltd. require? Who is Fangsheng Pharmaceutical hiring? Fangsheng Pharmaceutical recruitment: 经营管理类占比最多占40.9%,其次是医疗卫生/美容保健类占32.3%. What education can get in at Fangsheng Pharmaceutical? 本科占比最多占63.4%,其次是大专占16.4%. High education required at Fangsheng Pharmaceutical? 硕士占11.4%,博士占0.7%. Work experience required at Fangsheng Pharmaceutical? 5-10年占比最多占35.4%,其次是3-5年占25.6%. Where are the job locations at Fangsheng Pharmaceutical? 长沙占比最多占78.3%,其次是广州占7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 43,908.136万(元)
Legal Representative: 周晓莉
Date Established:
Credit Code: 91430000183855019M
Registered Address: 长沙市高新区麓松路789号

Partners & Suppliers

采购安乃近原料药 Source
供应商 原料药/中间体
方盛制药通过湖南九州通渠道销售其化学药品。 Source
合作客户 化学药品
中药饮片供应 Source
供应商 中药材/中药饮片
中药材供应 Source
供应商 中药材/中药饮片
原料药供应 Source
供应商 化学原料药

People who follow Fangsheng Pharmaceutical also follow

Fangsheng Pharmaceutical Competitors (Similar Companies)

制药/药业 医药 生物医药 医药工业
“Biological diagnostic reagents and pharmaceuticals”
药品零售 大健康 医药工业 医药流通
“Hunan Province Top Ten Pharmaceutical Industry Enterprises”
制药/药业 生物医药 抗生素 仿制药
多糖 核酸 生物制剂 医药
生产 化工/化学原料 化学品 新材料
生物科技/生物工程 生物医药 新药研发 SMO
生物科技/生物工程 诊断试剂 制片机 试剂
“Dedicated to the popularization of blood glucose meters in China and t”
“To become a benchmark enterprise in women's health and a brand enterpr”
生物医药 原料药 硝酸 精细化工
工程咨询 工程设计 工程总承包/EPC 废物处理
“一家致力于打造全球多肽新药研发新引擎的生物医药高科技企业”
“One-stop CRO services for pharmaceutical sciences and clinics”

Discover Great Companies, Discover Great Clients

长沙公司名录 长沙“Yuelu District”公司名录 长沙“制药/药业”公司名录 长沙“新药研发”公司名录 长沙“药物研发”公司名录 长沙“生物制药”公司名录 长沙“生物科技/生物工程”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates